Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesAbrar Choudhury, David R. Raleigh, Penny K. Sneed et al.|Nature Genetics|2022Cited by 296
Meningioma metastases: incidence and proposed screening paradigmCecilia L. Dalle Ore, Michael McDermott, Stephen T. Magill et al.|Journal of neurosurgery|2019Cited by 97
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresAbrar Choudhury, David R. Raleigh, William Chen et al.|Neuro-Oncology|2022Cited by 69
Surgical outcomes after reoperation for recurrent skull base meningiomasStephen T. Magill, Michael McDermott, David S. Lee et al.|Journal of neurosurgery|2018Cited by 65
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto‐Hope G. Lucas, David R. Raleigh, Kanish Mirchia et al.|Nature Genetics|2024Cited by 53